BR9302430A - Composto,composicao farmaceutica e metodo para tratar injecoes virais e neoplasma - Google Patents

Composto,composicao farmaceutica e metodo para tratar injecoes virais e neoplasma

Info

Publication number
BR9302430A
BR9302430A BR9302430A BR9302430A BR9302430A BR 9302430 A BR9302430 A BR 9302430A BR 9302430 A BR9302430 A BR 9302430A BR 9302430 A BR9302430 A BR 9302430A BR 9302430 A BR9302430 A BR 9302430A
Authority
BR
Brazil
Prior art keywords
neoplasm
injections
compound
pharmaceutical composition
treating viral
Prior art date
Application number
BR9302430A
Other languages
English (en)
Inventor
Larry Wayne Hertel
Julian Stanley Kroin
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9302430A publication Critical patent/BR9302430A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR9302430A 1992-06-22 1993-06-21 Composto,composicao farmaceutica e metodo para tratar injecoes virais e neoplasma BR9302430A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90231492A 1992-06-22 1992-06-22

Publications (1)

Publication Number Publication Date
BR9302430A true BR9302430A (pt) 1994-01-11

Family

ID=25415673

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9302430A BR9302430A (pt) 1992-06-22 1993-06-21 Composto,composicao farmaceutica e metodo para tratar injecoes virais e neoplasma

Country Status (21)

Country Link
US (1) US5430026A (pt)
EP (1) EP0576230B1 (pt)
JP (1) JPH0656876A (pt)
KR (1) KR940005657A (pt)
CN (1) CN1084177A (pt)
AT (1) ATE137243T1 (pt)
AU (1) AU664096B2 (pt)
BR (1) BR9302430A (pt)
CA (1) CA2098875A1 (pt)
CZ (1) CZ123193A3 (pt)
DE (1) DE69302330T2 (pt)
DK (1) DK0576230T3 (pt)
ES (1) ES2087657T3 (pt)
FI (1) FI932870L (pt)
GR (1) GR3020064T3 (pt)
HU (1) HUT64769A (pt)
IL (1) IL106079A0 (pt)
MX (1) MX9303711A (pt)
NO (1) NO932289L (pt)
PL (1) PL299414A1 (pt)
YU (1) YU43193A (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
GB9708611D0 (en) 1997-04-28 1997-06-18 Univ Cardiff Chemical compounds
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
GB0009486D0 (en) 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
DK1465615T3 (da) 2002-01-15 2012-11-12 Dartmouth College Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
KR20040094692A (ko) * 2002-02-14 2004-11-10 파마셋, 리미티드 변형된 불소화 뉴클레오사이드 유사체
US7265096B2 (en) 2002-11-04 2007-09-04 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
CA2508479A1 (en) * 2002-12-03 2004-06-17 Baylor University Compounds resistant to metabolic deactivation and methods of use
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
KR100874052B1 (ko) * 2004-12-17 2008-12-12 일라이 릴리 앤드 캄파니 젬시타빈의 아미드 전구약, 그의 조성물 및 그의 용도
JP2008531680A (ja) * 2005-03-04 2008-08-14 ダブール・ファーマ・リミテッド βアノマーが富化された２１−デオキシ−２１，２１−ジフルオロ−Ｄ−リボフラノシルヌクレオシドの調製のための中間体と方法
CN1693309A (zh) * 2005-04-18 2005-11-09 成都正开生物科技发展有限公司 N4－（取代的氧羰基）－2′，2′－二氟－2′－脱氧胞苷衍生物及其应用
AT502635A1 (de) * 2005-11-09 2007-05-15 Saischek Und Partner Meg Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung
GB0609178D0 (en) 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
US7714012B2 (en) 2006-11-17 2010-05-11 Trustees Of Dartmouth University Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
US8299046B2 (en) 2006-11-17 2012-10-30 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
PL2252283T3 (pl) 2008-01-11 2019-09-30 Reata Pharmaceuticals, Inc. Syntetyczne triterpenoidy i sposoby zastosowania w leczeniu choroby
RS55631B1 (sr) 2008-04-18 2017-06-30 Reata Pharmaceuticals Inc Antioksidansni modulatori upale: c-17 homologisani derivati oleanolinske kiseline
CN102164941B (zh) 2008-04-18 2015-05-27 里亚塔医药公司 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
WO2009129546A1 (en) 2008-04-18 2009-10-22 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
WO2009146216A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CA2721665C (en) 2008-04-18 2017-01-24 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
DE102011077393A1 (de) 2011-06-10 2012-12-13 Johannes Reinmüller Antiinfektives Mittel
HRP20181187T1 (hr) 2012-04-04 2018-09-21 Halozyme, Inc. Kombinirana terapija s hijaluronidazom i taksanom koji ciljano djeluje na tumor
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
BR112015009636A8 (pt) * 2012-10-29 2018-04-17 Cocrystal Pharma Inc composto, métodos para o tratamento de um hospedeiro infectado, métodos para a prevenção de uma infecção, métodos para a redução da atividade biológica de uma infecção e uso de um composto
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
GR1009958B (el) * 2019-04-24 2021-03-18 ΕΝΟΡΑΣΙΣ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΚΑΙ ΙΑΤΡΙΚΩΝ ΥΛΙΚΩΝ ΚΑΙ ΜΗΧΑΝΗΜΑΤΩΝ με δ.τ. "ΕΝΟΡΑΣΙΣ Α.Ε." Παραγωγα γεμσιταβινης και μεθοδοι δημιουργιας παραγωγων γεμσιταβινης
CN116731097A (zh) * 2023-06-14 2023-09-12 河南省科学院高新技术研究中心 氨基酸甲酯取代的尿苷及其衍生物、其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ZA859008B (en) * 1984-12-04 1987-07-29 Lilly Co Eli The treatment of tumors in mammals
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
CA1324128C (en) * 1987-08-28 1993-11-09 Ta-Sen Chou 2', 2'-difluoronucleosides
US4914028A (en) * 1988-02-10 1990-04-03 Eli Lilly And Company Method of preparing beta-2',2'-difluoronucleosides
IL89258A0 (en) * 1988-02-16 1989-09-10 Lilly Co Eli 2',3'-dideoxy-2',2'-difluoro-nucleosides
EP0339161A1 (en) * 1988-04-01 1989-11-02 Merrell Dow Pharmaceuticals Inc. Novel fluorophosphonate nucleotide derivatives
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
EP0523110A1 (en) * 1990-04-04 1993-01-20 Nycomed Imaging As Nucleoside derivatives

Also Published As

Publication number Publication date
ATE137243T1 (de) 1996-05-15
MX9303711A (es) 1994-05-31
CA2098875A1 (en) 1993-12-23
AU664096B2 (en) 1995-11-02
AU4134893A (en) 1993-12-23
DK0576230T3 (da) 1996-05-20
NO932289D0 (no) 1993-06-21
HUT64769A (en) 1994-02-28
EP0576230A1 (en) 1993-12-29
GR3020064T3 (en) 1996-08-31
FI932870A7 (fi) 1993-12-23
JPH0656876A (ja) 1994-03-01
IL106079A0 (en) 1993-10-20
EP0576230B1 (en) 1996-04-24
DE69302330D1 (de) 1996-05-30
KR940005657A (ko) 1994-03-22
CN1084177A (zh) 1994-03-23
CZ123193A3 (en) 1994-04-13
ES2087657T3 (es) 1996-07-16
DE69302330T2 (de) 1996-10-10
HU9301824D0 (en) 1993-09-28
FI932870L (fi) 1993-12-23
FI932870A0 (fi) 1993-06-21
US5430026A (en) 1995-07-04
YU43193A (sh) 1997-01-08
PL299414A1 (en) 1993-12-27
NO932289L (no) 1993-12-23

Similar Documents

Publication Publication Date Title
BR9302430A (pt) Composto,composicao farmaceutica e metodo para tratar injecoes virais e neoplasma
KR950700298A (ko) 뉴클레오시드 치료제(Therapeutic Nucleosides)
DK0973735T3 (da) Polyaromatiske antivirale præparater
DK97283A (da) Fremgangsmaade til fremstilling af derivater af 1,2,4-triaziner og -pyridiner
DE69435118D1 (de) Gereinigte Zusammensetzungen von Newcastle-Krankheitvirus
AU6497694A (en) Method for selective inactivation of viral replication
ATE124936T1 (de) 5-benzyl barbitursäurederivate.
DE3769083D1 (de) Positionieren von glasscheiben, um diese zu biegen.
PT94210A (pt) Processo para a preparacao de novos derivados piranilicos de cianoguanidina com accao estimulante dos canais de potassio
DE69115108D1 (de) Antiretrovirale Basen.
FI893112A0 (fi) Antivirala kombinationer och deras kompositioner.
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
BR9302426A (pt) Processo para a separacao de uma mistura anomerica
IT8021929A0 (it) Metodo ed apparecchio per controllare le emissioni di particelle scaricate da impianti di combustione.
DK0580753T3 (da) Pyrimidinderivater til forøgelse af antitumoraktivitet
AU3170193A (en) Therapeutic nucleosides
FI911751A0 (fi) Nya a-mannosidas- och fukosidasinhibitorer.
DE69105556D1 (de) Glaskeramikzusammensetzung mit hoher Kristallisationsgeschwindigkeit zur Glasierung von keramischen Werkstücken, insbesondere Fliesen.
DK523786A (da) Toerrekammer til behandling af emner, isaer paneler, plader og lignende genstande, som er malet med f.eks. fernis, lak eller maling
ATE147741T1 (de) Substituierte pyridine als hmg-coa-reduktase- inhitoren
ATE129068T1 (de) Verwendung einer ofenrolle.
RU93046286A (ru) 2'-дезокси-2', 2'-дифтор (4-замещенный пиримидин)нуклеозиды, обладающие противовирусной и противораковой активностью, промежуточные соединения и способ лечения
FI970666L (fi) Välituotteita ja menetelmiä niiden valmistamiseksi
FI824330A7 (fi) 1-(3-nitrofenyyli)pyrido/2,3- d/pyrimidiini-2,4(1H,3H)dionit ja 1- (3-nitrofenyyli)kinatsoliini-2,4-(1H,3H)dionit ihon kautta vaikuttavina lääkkeinä.
DK432284A (da) Befaestigelsesklemme, isaer til fastspaending af staenklapper paa automobiler

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
HKFN Application deemed withdrawn (deleted)
FA7 Application withdrawn (art. 18 par. 1 of law 5772/71) - being contrary to morals, good customs and public security, order and health